Potential Benefits of Carnitine in HIV-Positive Patients
Authors:
- 21 December 2011
- journal article
- Published by Taylor & Francis in Future Virology
- Vol. 7 (1) , 73-83
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Effect of Antioxidants on Mitochondrial Function in HIV-1–Related Lipoatrophy: A Pilot StudyAIDS Research and Human Retroviruses, 2010
- Effect ofL-Acetylcarnitine on Body Composition in HIV-related LipodystrophyHormone and Metabolic Research, 2009
- Acetyl‐l‐carnitine and nucleoside reverse transcriptase inhibitor‐associated neuropathy in HIV infectionHIV Medicine, 2009
- Review: Clinical aspects of the management of HIV lipodystrophyBritish Journal of Diabetes, 2008
- Long-Term Effect of Acetyl-L-Carnitine for Antiretroviral Toxic NeuropathyHIV Research & Clinical Practice, 2005
- L-Carnitine, Immunomodulation, and Human Immunodeficiency Virus (HIV)-related DisordersMonatshefte für Chemie - Chemical Monthly, 2005
- Acetyl-l-carnitineAIDS, 2004
- Low serum carnitine in HIV-infected children on antiretroviral treatmentEuropean Journal of Clinical Nutrition, 2003
- The relevance of apoptosis to AIDS pathogenesisTrends in Cell Biology, 1995
- Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infectionPathology, 1992